A side-by-side evaluation of [18F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography
A side-by-side evaluation of [18F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography |
|
https://doi.org/10.18632/oncotarget.27184
Athira Narayan,
Yu Yan,
Ala Lisok,
Mary Brummet,
Martin G. Pomper,
Wojciech G. Lesniak,
Robert F. Dannals,
Vanessa F. Merino,
and Babak Behnam Azad
|
| 5731-5744 |
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells |
|
https://doi.org/10.18632/oncotarget.27196
Harish Potu,
Malathi Kandarpa,
Luke F. Peterson,
Nicholas J. Donato,
and Moshe Talpaz
|
| 5745-5754 |
PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors
PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors |
|
https://doi.org/10.18632/oncotarget.27206
Amanda M. Smith,
Christine R.C. Zhang,
Alexandre S. Cristino,
John P. Grady,
J. Lynn Fink,
and Andrew S. Moore
|
| 5755-5767 |
New prognostic markers revealed by RNA-Seq transcriptome analysis after MYC silencing in a metastatic gastric cancer cell line
New prognostic markers revealed by RNA-Seq transcriptome analysis after MYC silencing in a metastatic gastric cancer cell line |
|
https://doi.org/10.18632/oncotarget.27208
Luana de O. Lopes,
Jersey H. Maués,
Hygor Ferreira-Fernandes,
France K. Yoshioka,
Severino C. Sousa Júnior,
Alcemir R. Santos,
Helem F. Ribeiro,
Juan A. Rey,
Paulo C. Soares,
Rommel R. Burbano,
and Giovanny R. Pinto
|
| 5768-5779 |
Mechanisms by which PE21, an extract from the white willow Salix alba, delays chronological aging in budding yeast
Mechanisms by which PE21, an extract from the white willow Salix alba, delays chronological aging in budding yeast |
|
https://doi.org/10.18632/oncotarget.27209
Younes Medkour,
Karamat Mohammad,
Anthony Arlia-Ciommo,
Veronika Svistkova,
Pamela Dakik,
Darya Mitrofanova,
Monica Enith Lozano Rodriguez,
Jennifer Anne Baratang Junio,
Tarek Taifour,
Paola Escudero,
Fani-Fay Goltsios,
Sahar Soodbakhsh,
Hana Maalaoui,
Éric Simard,
and Vladimir I. Titorenko
|
| 5780-5816 |
Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center
Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center |
|
https://doi.org/10.18632/oncotarget.27212
Noura J. Choudhury,
Mansooreh Eghtesad,
Sabah Kadri,
John Cursio,
Lauren Ritterhouse,
Jeremy Segal,
Aliya Husain,
and Jyoti D. Patel
|
| 5817-5823 |
Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity
Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity |
|
https://doi.org/10.18632/oncotarget.27217
Mark R. Woodford,
Michael Hughes,
Rebecca A. Sager,
Sarah J. Backe,
Alexander J. Baker-Williams,
Michael S. Bratslavsky,
Joseph M. Jacob,
Oleg Shapiro,
Michael Wong,
Gennady Bratslavsky,
Dimitra Bourboulia,
and Mehdi Mollapour
|
| 5824-5834 |
Engineered human platelet-derived microparticles as natural vectors for targeted drug delivery
Engineered human platelet-derived microparticles as natural vectors for targeted drug delivery |
|
https://doi.org/10.18632/oncotarget.27223
Jyotsna Kailashiya,
Vineeta Gupta,
and Debabrata Dash
|
| 5835-5846 |
GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways
GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways |
|
https://doi.org/10.18632/oncotarget.27226
Aimee T. Farria,
Lisa Maria Mustachio,
Zeynep H. Coban Akdemir,
and Sharon Y.R. Dent
|
| 5847-5858 |
Clinicopathological correlation of immune response in human cancers
Clinicopathological correlation of immune response in human cancers |
|
https://doi.org/10.18632/oncotarget.27231
Yuexin Liu
|
| 5859-5870 |
Two novel ligand-independent variants of the VEGFR-1 receptor are expressed in human testis and spermatozoa, one of them with the ability to activate SRC proto-oncogene tyrosine kinases
Two novel ligand-independent variants of the VEGFR-1 receptor are expressed in human testis and spermatozoa, one of them with the ability to activate SRC proto-oncogene tyrosine kinases |
|
https://doi.org/10.18632/oncotarget.27232
Belen Alvarez-Palomo,
Carme Barrot-Feixat,
Helena Sarret,
Jordi Requena,
Montserrat Pau,
Jose-Manuel Vidal-Taboada,
Rafael Oliva,
Josep-Lluis Ballesca,
Michael J. Edel,
and Jovita Mezquita-Pla
|
| 5871-5887 |
Correction: Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors
Correction: Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors |
|
https://doi.org/10.18632/oncotarget.27253
Ming Xu,
Changhong Zhu,
Xian Zhao,
Cheng Chen,
Hailong Zhang,
Haihua Yuan,
Rong Deng,
Jinzhuo Dou,
Yanli Wang,
Jian Huang,
Qin Chen,
Bin Jiang,
and Jianxiu Yu
|
| 5888-5888 |
Correction: Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells
Correction: Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells |
|
https://doi.org/10.18632/oncotarget.27254
Teresa Bernadette Steinbichler,
Alshaimaa Abdelmoez,
Veronika Maria Metzler,
Daniel Dejaco,
Herbert Riechelmann,
Jozef Dudas,
and Ira-Ida Skvortsova
|
| 5889-5889 |
Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway |
|
https://doi.org/10.18632/oncotarget.27255
Muhammad Bakhait Rahmat,
Songjing Zhang,
and Cheng-Gee Koh
|
| 5890-5891 |
